Background： Collapsin response mediator protein-2 （CRMP2） has been shown to be involved in ischemia/hypoxia （IH） injury. We determined whether CRMP2 modulates ischemic injury in the retinal of Ocular ischemic syn...Background： Collapsin response mediator protein-2 （CRMP2） has been shown to be involved in ischemia/hypoxia （IH） injury. We determined whether CRMP2 modulates ischemic injury in the retinal of Ocular ischemic syndrome （OIS）. This study was to explore the molecular mechanisms underlying O1S in a novel mice model. Methods： Experiments were performed oil adult male C57/BL6 mice that received bilateral internal carotid arteries ligation for 1,2, or 4 weeks. The mice received injection of calpeptin group before occlusion for 4 weeks or not. The expression of CRMP2 in the retinal was exalnined by western blotting （WB） analysis and immunohistochemical analysis （IHC）. The effects of ischemic injury on retinal were evaluated by fundus examination, fundus fluorescein angiography, electroretinogram, cell cotinting of retinal ganglion cell （RGC）, and measurement of the thickness of the retina. Results： The veins dilated after chronic ischemia. In the electroretinography, the amplitudes of a- and b-waves kept diminishing in an ischemia time-dependent manner. Moreover, the tail vein-retinal circulation time prolonged in the l- and 2-week group. In comparison, thickness of the retina decreased gradually with the ischemia time elapsed. WB analysis showed the CRMP2 and p-CRMP2 levels decreased in the 2- and 4-week groups. The results of IHC analysis were compatible with our results of WB. The loss of RGCs, decrease of the total reaction time and reduction of CRMP2 was alleviated by intravitreal injection of calpeptin. Conclusions： These results revealed that bilateral ligation of the internal carotid artery causes retinal ischemia in mice. Moreover, CRMP2 might play a pivotal role during the ischemic injury in the retina and inhibit the cleavage of CRM P2 can ameliorate the IH injury.展开更多
文摘Background： Collapsin response mediator protein-2 （CRMP2） has been shown to be involved in ischemia/hypoxia （IH） injury. We determined whether CRMP2 modulates ischemic injury in the retinal of Ocular ischemic syndrome （OIS）. This study was to explore the molecular mechanisms underlying O1S in a novel mice model. Methods： Experiments were performed oil adult male C57/BL6 mice that received bilateral internal carotid arteries ligation for 1,2, or 4 weeks. The mice received injection of calpeptin group before occlusion for 4 weeks or not. The expression of CRMP2 in the retinal was exalnined by western blotting （WB） analysis and immunohistochemical analysis （IHC）. The effects of ischemic injury on retinal were evaluated by fundus examination, fundus fluorescein angiography, electroretinogram, cell cotinting of retinal ganglion cell （RGC）, and measurement of the thickness of the retina. Results： The veins dilated after chronic ischemia. In the electroretinography, the amplitudes of a- and b-waves kept diminishing in an ischemia time-dependent manner. Moreover, the tail vein-retinal circulation time prolonged in the l- and 2-week group. In comparison, thickness of the retina decreased gradually with the ischemia time elapsed. WB analysis showed the CRMP2 and p-CRMP2 levels decreased in the 2- and 4-week groups. The results of IHC analysis were compatible with our results of WB. The loss of RGCs, decrease of the total reaction time and reduction of CRMP2 was alleviated by intravitreal injection of calpeptin. Conclusions： These results revealed that bilateral ligation of the internal carotid artery causes retinal ischemia in mice. Moreover, CRMP2 might play a pivotal role during the ischemic injury in the retina and inhibit the cleavage of CRM P2 can ameliorate the IH injury.
